The COVID-19 vaccine Corbevax from Biological E has been approved for booster doses in people aged 18 and up. It can be given to people six months after they’ve taken the first two doses of either Covaxin or Covishield for limited usage in an emergency, according to a statement released today by the business. Corbevax is the first heterologous Covid booster in India.
“This approval, which will resolve the requirement for COVID-19 booster doses in India, makes us extremely happy. In our COVID-19 vaccine journey, we’ve reached another another milestone. This approval highlights Corbevax’s continued world-class safety standards and high immunogenicity “Mahima Datla, Managing Director of Biological E, stated in a release today.